MitoRx Therapeutics closed a Seed round (amount undisclosed) in Apr 2022. The company is based in Oxford, UK. Investors in the round: Longevitytech.fund, Oxford Technology Management, Science Angel Syndicate Network and 3 others. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
